Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

IBUPROFEN TABLETS

Awarded
SPE2DP26F7911Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The Defense Logistics Agency awarded a delivery order under contract SPE2DX25D9900 to DMS PHARMACEUTICAL GROUP INC (CAGE 1UNB0) for the supply of 4.000 bottles of ibuprofen tablets, identified by NSN 6505012149061, with a total contract value of $22.76. The award was issued on July 21, 2026, under solicitation SPE2DP26F7911, with delivery mandated for August 5, 2026, to the destination address in Morrisville, North Carolina. The contract operates under FOB Destination terms, with payment liability assigned to the contractor, and requires traceable shipping methods—parcel post is prohibited. Item identification includes the NDC numbers NDC00904-5855-60, NDC42291-0339-01, and NDC55111-0684-01, along with associated CAGE codes for manufacturer verification and the Transportation Control Number W51J4X62020015 for logistics tracking. The unit price is fixed at $5.69 per bottle with no variance allowable in quantity. No options, extensions, or additional line items are included. The procurement reflects a low-value, commoditized pharmaceutical acquisition under a federal supply schedule, consistent with DLA’s routine pharmaceutical sourcing practices. The award does not include explicit clause listings, detailed specifications, quality standards, packaging requirements, or evaluation criteria beyond basic delivery and identification parameters. Acceptance occurs at the destination by the government, and while no formal Section C Statement of Work or Section M evaluation factors are provided, the structure and context support a Low Price Technically Acceptable source selection approach. Accounting identifiers include DIC A0A, FC 62, and PR 7017583140, and invoicing is likely handled via WAWF, though no formal payment office or remittance instructions are documented. No socioeconomic certifications, representation statements beyond the awardee’s CAGE code, or special contract requirements beyond shipping and labeling directives are indicated. The contract is a single-line, fixed-quantity award with no variation permitted, and no attachments, clause alternates, or referenced MIL-STDs are specified.

General Info

DMS PHARMACEUTICAL GROUP INC to supply ibuprofen tablets for $22.76 under DLA contract on July 21, 2026.

Contract Value

$22.76

NAICS

424210 - Drugs and Druggists' Sundries Merchant Wholesalers

Place of Performance

IL, USA

Set-Aside

NONE

Award Issued Date

Documents

2

Contract SPE2DP26F7911 for Ibuprofen Tablets

PDF, High priority: read this firstcontract-document
High

SPE2DP26F7911 Unreadable Document

PDF, Low priorityother
Low

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseAwarded
Posted

Award Notice

Awarded

Contract was awarded

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Logistics Agency
ContactsNo contacts available
OfficeUSA
Office AddressUSA
ContactsNo contact information available

Full Description

Show more
DLA award SPE2DP26F7911 posted on DIBBS. Awardee: DMS PHARMACEUTICAL GROUP INC (CAGE 1UNB0) Total Contract Price: $22.76 Award Date: 07-21-2026 Delivery order under: SPE2DX25D9900 Line items: - IBUPROFEN TABLETS (NSN/Part 6505012149061, PR 7017583140)

Similar Contracts

Same NAICS industry code

NAICS: 424210
New
SLED
Purchase of Antibiotics
Solicitation # 2026-Informal-0210
The City of Pasadena Public Health Department is soliciting quotes for a one-time purchase of antibiotics to be stockpiled for city staff and their dependents in preparation for public health emergencies involving Category A agents, such as anthrax, plague, or tularemia. The procurement consists of 30,000 tablets of Ciprofloxacin (500mg/dose) and 200,000 tablets of Doxycycline Hyclate (100mg/dose). All materials must be delivered to the Pasadena Public Health Department by June 30, 2027, with a required delivery lead time of four business days from the date of order. Vendors must adhere to strict FDA and CDC regulatory standards for manufacturing, distribution, and recordkeeping. Key requirements include full lot-level traceability, accurate labeling of lot numbers and expiration dates, and strict compliance with cold-chain and temperature-controlled shipping guidelines using monitoring devices. Bidders must submit their proposals electronically via the City of Pasadena eProcurement Portal by October 28, 2026. Required documentation includes a Unique Entity Identifier (UEI), IRS Form W-9, a Pasadena Business License, and various certifications regarding lobbying, equal employment opportunity, and federal representations. This procurement is subject to several federal and local regulations, including FEMA Supplemental Terms and Conditions, the Davis-Bacon Act for prevailing wages, and domestic preference guidelines under CFR 200.322. The contract operates on Net 30 payment terms. Evaluation of bidders will include a review of relevant past performance and the submission of required legal and workforce utilization forms.
Public Health Department

POSTED

about 18 hours ago

DEADLINE

in 7 days
View Details
NAICS: 424210
New
DIBBS
SUNSCREEN PREPARATION
Solicitation # SPE2DP-27-T-0183
This solicitation, identified as SPE2DP-27-T-0183, is a Request for Quotations for the procurement of sunscreen preparation under NSN 6505-01-657-9247. The required product is an over-the-counter topical sunscreen with an SPF of 50, containing 4.5% titanium dioxide and 4% zinc oxide. It must be sweat and water-resistant for 80 minutes, hypoallergenic, oil-free, PABA-free, and biodegradable. The unit of issue is a package of 24 three-ounce tubes. The product has a total shelf life of 24 months, with a minimum of 21 months remaining upon receipt by the government. Storage requirements are specified between 15 and 30 degrees Celsius in a cool, dry place. The contract specifies a delivery timeframe of five days with an original required delivery date of July 21, 2026. Delivery is FOB Destination, with shipments directed to locations including Fort Bragg, North Carolina, and North Stonington, Connecticut. Packaging must adhere to ASTM D3951 for non-hazardous materials or TQ requirement IP025 for hazardous materials, with palletization following RP001. Marking must comply with Medical Marking Standard No. 1, which supersedes MIL-STD-129. Inspection and acceptance will occur at the destination. Administrative requirements include the use of the Wide Area WorkFlow system for electronic invoicing and payment requests. The procurement is subject to various federal regulations, including the Buy American Act and DFARS cybersecurity reporting standards. Quotes must be submitted via the DLA Internet Bid Board System. The solicitation is managed by the Medical Supply Chain Pharma FSA under the Department of Defense, with a primary point of contact at DLA.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

2 days ago

DEADLINE

in 5 days
View Details
NAICS: 424210
New
DIBBS
REHYDRATION SALTS FOR
Solicitation # SPE2DP-27-T-0184
Solicitation SPE2DP-27-T-0184 is a request for quotations from the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of lemon-flavored electrolyte oral rehydration powder, identified by NSN 6505-01-646-2692. The product is an over-the-counter oral solution powder provided in packages containing 100 packets, with each 21 gram packet formulated to provide 665 mg of sodium, 390 mg of potassium, 80 mg of citrate, 83 mg of magnesium, and 3 mg of zinc when mixed with 16.9 fluid ounces of water. The items have a non-extendable shelf life of 24 months and are regulated by the FDA. The contract includes three CLINs with total quantities of 13 packages to be delivered to various destinations, including the USNS Richard E Byrd, USNS John Lenthall, and NAVSHIPYD & IMF Det Guam. Delivery is required within five days after the order, with required delivery dates set for October 27 and 28, 2026. Shipping is FOB Destination, and inspection and acceptance will occur at the destination. Packaging must comply with DLA Master List requirements, MIL-STD-129 for marking, and ASTM D3951 for non-hazardous commercial packaging, while palletization must follow RP001 standards. Administrative requirements include electronic invoicing via Wide Area WorkFlow and compliance with the Buy American Act, the Berry Amendment, and DFARS cybersecurity reporting standards. The solicitation is a candidate for automated award and incorporates the DLA Master Solicitation for Automated Simplified Acquisitions Revision 105. Evaluation may include a HUBZone price preference, and offers utilizing additive manufacturing are ineligible for award. The primary point of contact for this procurement is James McCullough.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

2 days ago

DEADLINE

in 5 days
View Details

More opportunities from Department Of Defense → Defense Logistics Agency

Same awarding agency

Earlier notices in this NAICS code

Posted before this notice, open and closed

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS